Pharmafile Logo

Genfar

- PMLiVE

Lilly to invest extra $180m in US insulin manufacturing

Response to growing demand for insulin pens for people with diabetes

- PMLiVE

Opportunities in the medical devices sector in India

Growing medical tourism, a burgeoning hospital sector and increased patient affluence make India an attractive prospect for medical device companies looking for partnerships

- PMLiVE

Eisai expands into Russia with Halaven launch

Breast cancer drug will be followed by epilepsy portfolio

- PMLiVE

Interview: Pierre Chancel, Sanofi Diabetes

The head of Sanofi Diabetes shares the company’s strategy to keep pace with the race against this ‘hidden disease’

Sanofi reception

Sanofi to act as contract manufacturer for Transgene

French biopharma partners with its big pharma compatriot on long-term deal

- PMLiVE

CHMP backs oral MS drugs from Sanofi, Biogen Idec

Tecfidera and Aubagio recommended for use in Europe

Sanofi reception

Follow-up data suggests long-term benefit of Sanofi’s Lemtrada in MS

Drug has a durable effect on relapse rates and disability progression

- PMLiVE

Baxter to cut 400 jobs in Puerto Rico

Plans to shift operations to the Dominican Republic

- PMLiVE

The reed that bends: pharma needs to adapt to cultural sensitivities

Is pharma’s increasing focus on emerging markets driving the need for a new approach to publication planning? Success depends upon adapting to cultural sensitivities

PRA acquires ClinStar to expand in Eastern Europe

CRO will manage clinical trials in Russia, Ukraine, Belarus and the Baltic States

Pharma deals during February 2013

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

- PMLiVE

Novo’s Lantus rival Tresiba hits European markets

Company says its insulin degludec is a more flexible alternative to Sanofi's product

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links